Associate Professor, Internal Medicine, Washington University School of Medicine
Oncology
Dr. Todd A. Fehniger, MD
|
|
Give Review
Todd Fehniger is an expert in the field of Oncology. He graduated from The Ohio State University College of Medicine. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Todd Fehniger is also published. He has 56 publications published. The lastest publication: "Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection.' Dr. Todd A. Fehniger accepts all Medicare patients.
Publications
- The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas.
- Memory NK Cells Take Out the (Mitochondrial) Garbage.
- MicroRNA-15/16 Antagonizes Myb To Control NK Cell Maturation.
- Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell Lymphoma.
- microRNA management of NK-Cell developmental and functional programs.
- Haploidentical transplantation using G-CSF-mobilized T-Cell replete PBSCs and post-transplantation CY after non-myeloablative conditioning is safe and is associated wi...
- Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells.
- MicroRNA-155 Tunes Both the Threshold and Extent of NK Cell Activation via Targeting of Multiple Signaling Pathways.
- Protective Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients Is Influenced by Co...
- MicroRNA regulation of natural killer Cells.
- Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein upregulates expression of the anti-leukemic microRNA-181a in Acute myeloid leukemia.
- Cytokine activation induces human memory-like NK Cells.
- A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin Lymphoma.
- Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin Lymphoma treated with standard salvage chemotherapy and autologous stem cell transplanta...
- Human NK Cells: SET to kill.
- A phase 2 study of high-dose lenalidomide as initial therapy for older patients with Acute myeloid leukemia.
- Complete characterization of the microRNAome in a patient with Acute myeloid leukemia.
- Next-generation sequencing identifies the natural killer Cell microRNA transcriptome.
- Latent herpesvirus infection arms NK Cells.
- Granzyme B is not required for regulatory T cell-mediated suppression of Graft-versus-host disease.
- Differential expression of granzyme B and C in murine cytotoxic lymphocytes.
- Single-agent lenalidomide induces complete remission of Acute myeloid leukemia in patients with isolated trisomy 13.
- Granzyme B and perforin are important for regulatory T Cell-mediated suppression of tumor clearance.
- Chronic lymphocytosis of functionally immature natural killer cells.
- Acquisition of murine NK Cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs.
- Hop cleavage and function in granzyme B-induced apoptosis.
- CD56bright natural killer Cells are present in human lymph nodes and are activated by T Cell-derived IL-2: a potential new link between adaptive and innate immunity.
- In vivo evidence for a dependence on interleukin 15 for survival of natural killer Cells.
- Natural killer cell receptors: new biology and insights into the graft-versus-Leukemia effect.
- Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with Acute myeloi...
- Fatal Leukemia in interleukin-15 transgenic mice.
- The biology of human natural killer-Cell subsets.
- Effects of antibody concentration on the separation of human natural killer Cells in a commercial immunomagnetic separation system.
- Ontogeny and expansion of human natural killer Cells: clinical implications.
- Natural killer Cells: biology and application in stem-Cell transplantation.
- Activation of T cells in the blood of patients with Acute malaria: proliferative activity as indicated by Ki-67 expression.
- Interleukin-2 and interleukin-15: immunotherapy for Cancer.
- New directions in natural killer cell-based immunotherapy of human Cancer.
- Biology and clinical impact of human natural killer Cells.
- NK Cell and DC interactions.
- Limited enGraftment of low-risk myelodysplastic syndrome cells in NOD/SCID gamma-C chain knockout mice.
- Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated Malignancies.
- Differential expression and function of L-selectin on CD56bright and CD56dim natural killer Cell subsets.
- Evaluation of natural killer Cell expansion and activation in vivo with daily subcutaneous low-dose interleukin-2 plus periodic intermediate-dose pulsing.
- Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer Cell progenitor that responds to interleukin-15.
- Natural killer Cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection.
- Differential cytokine and chemokine gene expression by human NK Cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate i...
- Costimulation of human natural killer Cells is required for interferon gamma production.
- Cutting edge: IL-15 costimulates the generalized Shwartzman reaction and innate Immune IFN-gamma production in vivo.
- Cytokine replacement in patients with HIV-1 non-Hodgkin's Lymphoma: the rationale for low-dose interleukin-2 therapy.
- Potential mechanisms of human natural killer Cell expansion in vivo during low-dose IL-2 therapy.
- Interleukin 15: biology and relevance to human Disease.
- Fatal Leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells.
- Interleukin-1beta costimulates interferon-gamma production by human natural killer Cells.
- Human natural killer Cells: a unique innate immunoregulatory role for the CD56(bright) subset.
Schools
Ohio State University College of Medicine
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Breast Cancer
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Washington University -
Washington University - Barnes-Jewish Hospital -
The Ohio State University College of Medicine
Hospital
-
Barnes-Jewish Hospital
Drug Facts
| NPI NUMBER | 1154447233 | |
| NPPES Provider LastName | FEHNIGER | |
| NPPES Provider FirstName | TODD | |
| NPPES Provider ZIPCode | 631101032 | |
| NPPES Provider State | MO | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 142.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 8.45 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1154447233 |
| Last Name Of The Provider | FEHNIGER |
| First Name Of The Provider | TODD |
| View All |
Similar Doctors
|
|
Dr. Alexander E. Denes, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jack M. Lionberger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nancy L. Bartlett, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ramaswamy Govindan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ron Bose, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian A. Van Tine, MD |
|
|
Dr. Benjamin R. Tan Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joel Picus, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Burton M. Needles, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lukas D. Wartman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John F. Dipersio, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Rama Suresh, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sandeep Sen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ravi Vij, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Maria Q. Baggstrom, MD
This Doctor is OpenDoctor Recommended.
|